Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies

This publication has 65 references indexed in Scilit:

• HIF-1: upstream and downstream of cancer metabolism
  Current Opinion in Genetics & Development, 2010
• Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
  British Journal of Cancer, 2009
• Quantitative optical spectroscopy can identify long-term local tumor control in irradiated murine head and neck xenografts
  Journal of Biomedical Optics, 2009
• Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
  British Journal of Cancer, 2008
• Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model
  Clinical Cancer Research, 2008
• Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR
  Biotechnology Letters, 2006
• Pharmacogenomic Identification of Novel Determinants of Response to Chemotherapy in Colon Cancer
  Cancer Research, 2006
• The anti-angiogenic basis of metronomic chemotherapy
  Nature Reviews Cancer, 2004
• The STATs of cancer — new molecular targets come of age
  Nature Reviews Cancer, 2004
• A new mathematical model for relative quantification in real-time RT-PCR
  Nucleic Acids Research, 2001